Press Release  | 

Exheus successfully completes 900,000 euros capital increase and prepares for international market entry

  • Exheus, a spin-off of Sant Pau Hospital Research Institute - IIB Sant Pau, Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Summit SL and Mobile World Capital Barcelona’s The Collider innovation program, received a private capital injection of 650,000 euros.

  • The AI based RNA analysis company obtained an additional 250,000 euros through a Ministry of Science and Innovation’S CDTI financing line.

  • The investment round will help reach new markets in Europe, establish a new commercial structure for international promotion, and develop a B2B focused digital platform.

Barcelona, ​​November 29, 2022.- Exheus, a genetics and data science company specializing in RNA analysis, completed a 900,000 euros fund raising, 70% from private funds.

Decelera Ventures I FCR was the operation’s lead investor (as a result of Exheus' participation in the Decelera Menorca program), together with WA4STEAM, NEXT GEN VENTURE A I, SCP and NEXT GEN VENTURE C I, SCP and more than a hundred business angels through Capital Cell, all of which resulted in a 650,000 euros fund raise. The Center for Technological and Industrial Development (CDTI), which is part of the Ministry of Science and Innovation and promotes innovation and technological development of Spanish companies, invested another 250,000 euros.

In addition to these 900,000 euros, Exheus was granted further 50,000 euros by EIT Health, the largest European organization for innovation in health, whose mission is to accelerate entrepreneurship and innovation, providing new opportunities and resources for the benefit of all citizens.

The funding will help Exheus expand into European markets; create a commercial structure in order to access health systems of niche countries; and work on the legal requirements necessary to operate internationally. Exheus also plans a B2B focused digitalization of the product developing a platform which would allow doctors and physicians to directly access and assess the patient's RNA test results.

“Our efforts during these last two years helped us develop the world’s most advanced health report. This capital increase will allow us to continue building Exheus and promote personalized medicine, both in Spain and other European markets, always focusing on improving the lives of patients”, says Teresa Tarragó, Exheus CEO.

A unique RNA test in the world

Exheus was born as a spin-off of the Sant Pau Hospital Complex Diseases Genomics Research Group - IIB Sant Pau, the Biomedical Engineering Research Center (CREB) of the Polytechnic University of Catalonia - BarcelonaTech (UPC) , Summit SL and Mobile World Capital Barcelona’s innovation program The Collider, which fosters science to market technology transfer.

Exheus sequences the expression of the genes (RNA) of a blood sample and analyzes all the information using artificial intelligence algorithms, thus detecting and correcting abnormalities that affect the health of the individual. Today, Exheus is the world’s most sophisticated commercial RNA analysis technology.

Exheus makes it possible for health professionals to offer personalized recommendations.



Exheus is a Spin-off of the Institut de Recerca de l’Hospital Sant Pau, the Polytechnic University of Catalonia (UPC) and Mobile World Capital Barcelona program The Collider. 

Founded in 2020 during the pandemic, Exheus raised 500,000 euros in 2021 and has taken part in several acceleration programs such as Google For Startups, Decelera or Kunsen VC. Besides, the company has received relevant international awards and published several papers in renown international scientific journals, and is currently working on others about the research carried out so far.


Mobile World Capital Barcelona is an initiative that drives the digital development of society and helps improve people's lives globally. With public and private support, MWCapital focuses its activity on four areas: accelerating innovation through digital entrepreneurship; the transformation of the industry through digital technology; the growth of digital talent among new generations and professionals; and reflection on the impact of technology on our society. Collectively, its programs are positively transforming the economy, education, and society. MWCapital hosts MWC in Barcelona and is the founder of 4 Years From Now (4YFN), the business platform for the startup community present at all MWC events around the world.